02.1 CoQ10 vs ubiquinol

Coenzyme Q10 vs ubiquinol: the oxidised and reduced forms

Technical document 02.1 · Reviewed 2026-11-20 · Coenzyme Q10

On this page
  1. One redox step, two materials
  2. The two catalog materials side by side
  3. The assay has to name the form and the wavelength
  4. The reduced form is the one that changes in storage
  5. The label and the mass arithmetic
  6. When to choose which

Ubiquinone and ubiquinol are the oxidised and reduced forms of coenzyme Q10. They differ by two electrons and two protons — C59H90O4 at 863.34 against C59H92O4 at 865.36 — so the mass difference is 2.02 units, about 0.23%. The practical difference is not the mass: it is the colour, the stability in air and light, the assay and the name on the label.

In one line

The two forms are one redox step apart — two electrons and two protons, 2.02 mass units — and that step decides the colour, the stability and the name on the label.

One redox step, two materials

Coenzyme Q10 has a benzoquinone head and a side chain of ten isoprene units. In ubiquinone the head carries two carbonyl groups; reduction turns them into two hydroxyl groups and gives ubiquinol. The side chain is unchanged, which is why the two materials are both lipophilic, both insoluble in water and both easy to confuse on a bench.

The pair is not a grade ladder. Ubiquinol is not a purer or stronger version of ubiquinone, and ubiquinone is not an earlier stage of the same specification. Each has its own CAS number, assay, stability profile and label name. A purchase order that says “CoQ10” has not chosen between them.

The mass difference is small enough to be ignored in a weighing room and large enough to matter on a label that declares the form. Two hydrogen atoms are 2.02 mass units, 0.23% of the molecule. That is a rounding difference, not a licence to substitute one form for the other.

The two catalog materials side by side

Ubiquinone (oxidised) and ubiquinol (reduced)
PropertyUbiquinone (coenzyme Q10)Ubiquinol
CAS number303-98-0992-78-9
FormulaC59H90O4C59H92O4
Molecular weight863.34865.36
Redox stateOxidisedReduced
AppearanceYellow to orange-yellow powderWhite to pale yellow powder or oil
Catalog assay98.0–101.0% by HPLC≥95.0% by HPLC
Counter-form limitNo numeric limit in the catalog; ubiquinol by an agreed redox methodUbiquinone ≤2.0%
SolubilityInsoluble in water; soluble in fats and organic solventsInsoluble in water; soluble in fats and organic solvents
Label nameCoenzyme Q10, ubiquinone or ubidecarenoneUbiquinol or reduced coenzyme Q10

The table separates two materials that share a name stem and most of their structure. It is not a conversion chart, and the two rows for the counter-form limit are not symmetrical: the ubiquinol specification carries a numeric ubiquinone ceiling because oxidation is its main failure route, while a ubiquinone lot has no numeric ubiquinol limit in the catalog and needs an agreed redox method if the form is in question.

The assay has to name the form and the wavelength

Ubiquinone is read by HPLC with UV detection at 275 nm and assayed on the anhydrous basis against a ubidecarenone standard. The catalog range is 98.0–101.0%. The same chromatographic run can carry the related-substance method, which bounds coenzymes Q7, Q8, Q9 and Q11 and the (2Z)-isomer.

Ubiquinol is a different assay. The reduced form absorbs at a different wavelength and has its own standard, and the specification sets ≥95.0% with ubiquinone ≤2.0%. Sample preparation matters: the material oxidises in air and light, so a sample left open on a bench can lose reduced content before it reaches the injector. A 275 nm assay calibrated for ubiquinone will not report ubiquinol correctly without its own standard and method.

“Total CoQ10” is a third figure. It is obtained by oxidising the sample and measuring the sum, which is useful for a total-content check but destroys the information about the form. A buyer who needs to know whether the powder is ubiquinone or ubiquinol needs the two-form method, not the total.

The reduced form is the one that changes in storage

Ubiquinone is already fully oxidised, so it does not convert to ubiquinol in storage. Its failure routes are light-driven isomerisation and related-substance formation, plus heat near its 48–52 °C melting range. The powder is stable enough for a sealed, light-resistant pack, but a clear jar and a warm shelf are still the wrong environment.

Ubiquinol has the opposite problem: oxygen takes it back to ubiquinone. Light and heat accelerate the reaction, and the ubiquinone limit of ≤2.0% is the specification's way of bounding it. That is why ubiquinol is supplied as a powder or an oil and why the pack needs an oxygen barrier; a nitrogen-flushed, opaque container is not the same starting point as a clear bottle.

Both forms need a light-resistant, sealed pack and a cool store. The difference is that ubiquinone's pack is mainly a light and moisture barrier, while ubiquinol's pack is also an oxygen barrier. A stability file written for one form does not describe the other.

The label and the mass arithmetic

The label has to name the form. In the EU and the US, “coenzyme Q10” is usually read as ubiquinone, but “usually” is not a specification. Write “ubiquinone” or “ubidecarenone” when that is the material, and “ubiquinol” or “reduced coenzyme Q10” when the reduced form is intended. A label that says only “CoQ10” leaves the form to the reader.

The mass conversion is nearly one to one. Multiply a ubiquinol quantity by 863.34 ÷ 865.36 = 0.9977 to express it as ubiquinone equivalent. A 100 mg ubiquinol label dose is 99.77 mg of ubiquinone equivalent; a 100 mg ubiquinone dose is 100.23 mg of ubiquinol. The numbers are close because the redox change is two hydrogen atoms, not a salt or an ester.

That arithmetic keeps a label and a weigh-up consistent; it does not make the forms interchangeable. The regulatory file, the stability data and the label name all follow the form, and a switch in either direction needs a change control, a new certificate and a fresh label review. The reduced form's market status is its own question and should not be inferred from the ubiquinone history.

When to choose which

Choose ubiquinone when the label, the specification and the market file name the oxidised form. It is the catalog powder, it has the defined 98.0–101.0% assay range and the long supplement history, and it suits capsules, tablets and oil suspensions. This is the form the coenzyme Q10 page supplies.

Choose ubiquinol when the label names the reduced form and the pack, the process and the market file are built around it. It is not a drop-in for the powder: the colour, the assay, the oxidation limit and the oxygen barrier all change. A formulator who wants to switch should approach it as a new ingredient rather than a new supplier.

Neither form is defined by a health claim on this site. The chemistry, the specification and the label are the subject here. Catalog data is on the coenzyme Q10 product page and the ubiquinol product page; the presentation choices are on the grades page; the separation is described in the HPLC method note; the release file is on the quality page.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation